// App-Quantinova.ai

936 : Frequency and Characteristics of Pegaspargase Antibodies in Adults Treated with a Pediatric Acute Lymphoblastic Leukemia Regimen

Researchers

Presenter

  • Patrick W. Burke

Principal Investigators

  • Ibrahim Aldoss

  • Laleh Ramezani

  • Vinod Pullarkat

  • Ann Mohrbacher

  • Dan Douer

Medical Centers

  • Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA

  • Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY

  • Department of Hematology and Hematopietic Cell Transplantation, City of Hope, Duarte, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Hydrocortisone

  • Pegaspargase

  • Oncaspar

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved